IDO1 and colorectal carcinoma: MiR-148a-3p and miR-448 respectively down-regulate the expression of calnexin (CANX) and indoleamine 2,3-dioxygenase 1 (IDO1), which enhances CD8+ T cell-mediated immune response in CRC (67, 68).